Pair Name | Epigallocatechin gallate, Vorinostat | ||
Phytochemical Name | Epigallocatechin gallate (PubChem CID: 65064 ) | ||
Anticancer drug Name | Vorinostat (PubChem CID: 5311 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Epigallocatechin gallate, Vorinostat | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | BIRC3 | hsa330 |
Up-regulation | Expression | CASP7 | hsa840 | |
In Vitro Model | MDA-MB-157 | Breast carcinoma | Homo sapiens (Human) | CVCL_0618 |
MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 | |
MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 | |
HCC1806 | Breast squamous cell carcinoma, acantholytic variant | Homo sapiens (Human) | CVCL_1258 | |
Result | The compounds were able to decrease the expression of cIAP2 while increasing the expression of pro-apoptotic caspase 7. There were also changes in histone modifications, suggesting a role of epigenetic mechanisms in these changes in expression of cIAP2. These changes resulted in an increase in apoptosis. SAHA and EGCG were also capable of limiting TNBC cell migration across a fibronectin (FN) matrix. |
No. | Title | Href |
---|---|---|
1 | SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly Through the Modulation of cIAP2. Anticancer Res. 2020 Jan;40(1):9-26. doi: 10.21873/anticanres.13922. | Click |